Evidence map›Paper›PMID 28261645›Full record

ArticleOncology and therapy2016

Concurrent Pilomatrix Carcinoma and Diffuse Large B-Cell Lymphoma.

Luis Parra, Marcos Martin, María Garrido, Jose María Pedraza, Javier Palazon, Manuel Robustillo, Daniel Grandes, Emilio Lagaron

Open access · goldAbstract read
In one paragraph

Article in Oncology and therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Luis ParraHospital 12 de Octubre, Madrid, Spain.
Marcos MartinPlastic Surgery Department, Hospital 12 de Octubre, Madrid, Spain.
María GarridoPathology Department, Hospital 12 de Octubre, Madrid, Spain.
Jose María PedrazaHospital 12 de Octubre, Madrid, Spain.
Javier PalazonHospital 12 de Octubre, Madrid, Spain.
Manuel RobustilloHospital 12 de Octubre, Madrid, Spain.
Daniel GrandesHospital 12 de Octubre, Madrid, Spain.
Emilio LagaronPlastic Surgery Department, Hospital 12 de Octubre, Madrid, Spain.
Research Institute Hospital 12 de Octubre · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pilomatrix carcinoma is a rare cutaneous tumor derived from follicular matrix cells. It may arise de novo or from a malignant transformation of a pilomatrixoma. The latter process has been associated with impaired immune system surveillance of the host caused by UV radiation or the onset of an underlying malignant neoplasm. We report a case of a 58-year-old man presenting with a long-standing pilomatrix carcinoma on the inner right leg after 10 years of repeated curettage of the lesion, concurrent with a high-grade B-cell lymphoma on the same extremity. We describe a rare association which highlights the necessity of close follow-up of patients with long-standing malignant skin tumors.

Indexed as

Long-standing skin lesionLymphomasPilomatrix carcinomaPilomatrixomaSkin tumors

Identifiers

PMID28261645
PMCPMC5315070
OpenAlexW2402317670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.